Company profile
Elektrofi company profile
Elektrofi develops biologic therapies through its hyper concentration microparticle platform technology, Hypercon. The company focuses on reengineering medicine delivery to support partners and patients with smarter administration methods. Elektrofi collaborates with other biopharma companies to develop new generation medicines that can be delivered subcutaneously.
Business identity
- Website
- https://www.elektrofi.com
- Contact email
- [email protected]
- Phone number
- 866-610-2683
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Panora, Iowa, United States
- Postal code
- 02210
- Country code
- US
- Continent
- North America